Level 7 Barrier Walls Will Be Removed for Duct Work
Beginning Monday night, Dec. 16, the contractor for the Medical Sciences Building (MSB) Rehabilitation Project will begin removing barrier walls on Level 7 in preparation for ceiling duct work. This work will be performed on weeknights between 8 p.m. and 6 a.m.
The barrier walls will be removed in two corridors that intersect with the main hallway: the hallway adjacent to Classroom 7051, and the hallway running from Suite 7002 to the CARE/Crawley Building bridge. This is necessary to remove old duct work that is above the ceilings and allow new work to go back in.
A temporary plastic ceiling will be put back to maintain the construction barrier for negative air containment, creating inward airflow and confining odors and particles to the work area. The walls will stay down for the remainder of the construction (through the end of 2014).
More Information
If you have questions about the MSB rehabilitation project, please call 513-558-2992 or emailmsbrehab@uc.edu. For more information, including archived updates, visit the MSB rehabilitation project website at www.med.uc.edu/MSBrehab.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.